Article info

Download PDFPDF

Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors
Free

Authors

  • Dimitra Dimopoulou Infectious Diseases’ Unit, Second Department of Paediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece PubMed articlesGoogle scholar articles
  • George Vartzelis Second Department of Pediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece PubMed articlesGoogle scholar articles
  • Foteini Dasoula Second Department of Pediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece PubMed articlesGoogle scholar articles
  • Maria Tsolia Infectious Diseases’ Unit, Second Department of Paediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece PubMed articlesGoogle scholar articles
  • Despoina Maritsi Immunology and Rheumatology Unit, Second Department of Paediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dimitra Dimopoulou, Second Department of Pediatrics, Aglaia Kiriakou Children's Hospital, Athens, Greece; dimi_med{at}hotmail.com
View Full Text

Citation

Dimopoulou D, Vartzelis G, Dasoula F, et al
Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors

Publication history

  • Received October 2, 2021
  • Accepted November 16, 2021
  • First published November 29, 2021.
Online issue publication 
March 10, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.